Richard Schilsky to Granulocyte-Macrophage Colony-Stimulating Factor
This is a "connection" page, showing publications Richard Schilsky has written about Granulocyte-Macrophage Colony-Stimulating Factor.
Connection Strength
0.129
-
Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study. J Natl Cancer Inst. 1993 Aug 18; 85(16):1319-26.
Score: 0.114
-
A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital. Clin Pharmacol Ther. 2004 Nov; 76(5):490-502.
Score: 0.015